Thomson Reuters Corporation Common Shares TRI

Zacks Investment Research 4 nov

Thomson Reuters reported Q3 2026 earnings of 81 cents per share, missing consensus estimates by 9%, and revenues of $1.83 billion, missing by 3.9%. Despite 14% earnings growth and 10% revenue growth year-over-year, the stock declined 9.9% following the results. AI products now represent 34% of contract value, and the company maintains a strong balance sheet with net leverage at 1.0x, though free cash flow fell 23% to $408 million.

The Motley Fool 4 nov

Thomson Reuters raised full-year organic revenue guidance to 9% following strong Q3 2026 results with 10% organic revenue growth. The company's next-generation AI tools are driving higher user engagement, government e-invoicing mandates are creating structural demand for compliance technology, and management plans to reinvest operating leverage into long-term AI-driven growth opportunities in 2027 rather than maximizing near-term profits.

Zacks Investment Research 3 nov

Thomson Reuters reported Q3 2026 earnings of $0.81 per share, missing the consensus estimate of $0.89 and representing an 8.99% earnings surprise. Revenue of $1.83 billion also fell short of expectations by 3.94%. The stock has underperformed the S&P 500 by 18.9% year-to-date. With a Zacks Rank #3 (Hold) rating, the stock is expected to perform in line with the market.

Zacks Investment Research 29 oct

APi reported Q3 2026 earnings of $0.50 per share, beating consensus estimates of $0.47, with revenues of $2.55 billion exceeding expectations by 6.90%. The company has outperformed consensus estimates three times over the last four quarters. Despite strong earnings, APi shares have underperformed the S&P 500 year-to-date, gaining 8.1% versus the market's 13.1%. The stock holds a Zacks Rank #2 (Buy) rating based on favorable estimate revision trends.

Zacks Investment Research 27 oct

AMN Healthcare Services (AMN) presents a better value opportunity than Thomson Reuters (TRI) based on fundamental metrics. AMN holds a Zacks Rank #2 (Buy) with a Value grade of A, featuring a forward P/E of 14.76 and PEG ratio of 1.68. TRI has a Zacks Rank #3 (Hold) with a Value grade of C, with a forward P/E of 27.37 and PEG ratio of 2.35. AMN's stronger earnings estimate revisions and more attractive valuation metrics make it the superior choice for value investors.